Due to their established roles in the aggressiveness and prognostication of several canine tumors, and the availability of therapeutic options regarding these markers for dogs, the main objective of this research is to analyze the expression levels of EGFR, Ki-67, and Cox-2 in canine cutaneous squamous cell carcinomas. This evidence concerns the gene PTGS2 and cutaneous squamous cell carcinoma.